Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-14
DOI
10.1038/srep33059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India
- (2016) H. Kaushal et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14
- (2016) Priscila L. dos Santos et al. PLoS Neglected Tropical Diseases
- Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice
- (2015) Parna Bhattacharya et al. INFECTION AND IMMUNITY
- Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum
- (2015) Jacqueline Araújo Fiuza et al. VACCINE
- Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals
- (2014) Himanshu Kaushal et al. BMC INFECTIOUS DISEASES
- Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control
- (2014) O. P. Singh et al. CLINICAL INFECTIOUS DISEASES
- Interleukin 17A Acts Synergistically With Interferon γ to Promote Protection Against Leishmania infantum Infection
- (2014) Manuela Sales Lima Nascimento et al. JOURNAL OF INFECTIOUS DISEASES
- Involvement of Different CD4+T Cell Subsets Producing Granzyme B in the Immune Response toLeishmania majorAntigens
- (2014) Ikbel Naouar et al. MEDIATORS OF INFLAMMATION
- In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
- (2014) Rym Chamakh-Ayari et al. PLoS One
- Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?
- (2014) S. Das et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
- (2014) Sreenivas Gannavaram et al. Frontiers in Immunology
- Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance
- (2013) Vasundhra Bhandari et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice
- (2013) R. Dey et al. JOURNAL OF IMMUNOLOGY
- CD8 T Cell Exhaustion in Human Visceral Leishmaniasis
- (2013) Shalini Gautam et al. JOURNAL OF INFECTIOUS DISEASES
- Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs
- (2013) Jacqueline Araújo Fiuza et al. VACCINE
- The Economic Value of a Visceral Leishmaniasis Vaccine in Bihar State, India
- (2012) Bruce Y. Lee et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Reassessment of Immune Correlates in Human Visceral Leishmaniasis as Defined by Cytokine Release in Whole Blood
- (2012) Om Prakash Singh et al. Clinical and Vaccine Immunology
- Visceral Leishmaniasis
- (2012) Johan van Griensven et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Tissue damage and immunity in cutaneous leishmaniasis
- (2012) S. Nylén et al. PARASITE IMMUNOLOGY
- Leishmanization revisited: Immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis
- (2012) Laura-Isobel McCall et al. VACCINE
- Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis
- (2012) Om Prakash Singh et al. PLoS Neglected Tropical Diseases
- IL-27 and IL-21 Are Associated with T Cell IL-10 Responses in Human Visceral Leishmaniasis
- (2011) Nasim Akhtar Ansari et al. JOURNAL OF IMMUNOLOGY
- Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study
- (2011) Kamlesh Gidwani et al. PLoS Neglected Tropical Diseases
- Evaluation of Ex Vivo Human Immune Response against Candidate Antigens for a Visceral Leishmaniasis Vaccine
- (2010) Rajiv Kumar et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Vaccines and vaccination strategies against human cutaneous leishmaniasis
- (2010) Ifeoma Okwor et al. Human vaccines & immunotherapeutics
- Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence
- (2010) Ranadhir Dey et al. MOLECULAR MICROBIOLOGY
- Designing Therapies against Experimental Visceral Leishmaniasis by Modulating the Membrane Fluidity of Antigen-Presenting Cells
- (2009) S. Banerjee et al. INFECTION AND IMMUNITY
- Intracellular Replication-Deficient Leishmania donovani Induces Long Lasting Protective Immunity against Visceral Leishmaniasis
- (2009) A. Selvapandiyan et al. JOURNAL OF IMMUNOLOGY
- Differentialin vitroCD4+/CD8+T-cell response to live vs. killedLeishmania major
- (2009) M. NATEGHI ROSTAMI et al. PARASITE IMMUNOLOGY
- Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example
- (2008) Christian Bogdan CELLULAR MICROBIOLOGY
- Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies
- (2008) Ifeoma Okwor et al. IMMUNOLOGIC RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now